1. Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines
   Sandra Huguenin et al, 2004, Molecular Cancer Therapeutics CrossRef
2. Nitric Oxide (NO) and NO Synthases (NOS)-Based Targeted Therapy for Colon Cancer
   Hao Wang et al, 2020, Cancers CrossRef
3. Myofiber degeneration/regeneration is induced in the cachecticApcMin/+mouse
   Kristen A. Mehl et al, 2005, Journal of Applied Physiology CrossRef